Using 3D cell culture models of iPSCs and iPSC‐derived human organoid cultures has helped researchers test drugs and treatments for CMT2 subtypes and elucidate the mechanism of PMP22 in CMT1A [106, 110, 111, 112]. This evidence concerns the gene PMP22 and Charcot-Marie-Tooth disease type 1A.